Peripheral neutron and gamma doses in radiotherapy with an 18 MV linear accelerator
- 1 August 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 110 (1-4) , 607-612
- https://doi.org/10.1093/rpd/nch135
Abstract
More and more attention is being given in radiotherapy to the doses received by organs other than the target organ. With increasing survival time of the patients, the risks of secondary malignancies need to be lowered as much as possible. So total body doses are worth estimating in radiotherapy. The introduction of intensity modulated radiotherapy (IMRT) needs an increase in the number of monitor units given to the patient. So there is a risk of increasing the peripheral doses using this technique. Another aspect, mostly neglected, is the neutron peripheral dose that occurs when LINAC energies above 8 MeV are used. We did measurements for both gammas and neutrons with an 18 MV Varian accelerator for a prostate cancer treatment. The measurements were done both free-in-air, at different depths in a plexi-phantom, and using a Rando–Alderson phantom. Effective doses for the total body outside the treatment area are estimated using these measurements.Keywords
This publication has 6 references indexed in Scilit:
- Peridose, a software program to calculate the dose outside the primary beam in radiation therapyRadiotherapy and Oncology, 2001
- DEPTH DOSE-EQUIVALENT AND EFFECTIVE ENERGIES OF PHOTONEUTRONS GENERATED BY 6–18 MV X-RAY BEAMS FOR RADIOTHERAPYHealth Physics, 2001
- Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck regionRadiotherapy and Oncology, 1999
- Fast neutron leakage in 18 MeV medical electron acceleratorRadiation Measurements, 1999
- A combined use of the BD-PND and BDT bubble detectors in neutron dosimetryRadiation Measurements, 1998
- In vivo neutron dosimetry during high-energy Bremsstrahlung radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1998